William Plovanic

Stock Analyst at Canaccord Genuity

(3.57)
# 878
Out of 5,041 analysts
151
Total ratings
48.89%
Success rate
5.84%
Average return

Stocks Rated by William Plovanic

Boston Scientific
Oct 23, 2025
Maintains: Buy
Price Target: $132
Current: $102.11
Upside: +29.27%
TransMedics Group
Oct 14, 2025
Maintains: Buy
Price Target: $142
Current: $132.74
Upside: +6.98%
AngioDynamics
Oct 3, 2025
Maintains: Buy
Price Target: $17$18
Current: $12.34
Upside: +45.87%
Tandem Diabetes Care
Sep 29, 2025
Maintains: Buy
Price Target: $24
Current: $15.07
Upside: +59.26%
DexCom
Sep 29, 2025
Maintains: Buy
Price Target: $106
Current: $71.56
Upside: +48.13%
iRhythm Technologies
Sep 29, 2025
Maintains: Buy
Price Target: $170$193
Current: $182.70
Upside: +5.64%
Artivion
Sep 29, 2025
Maintains: Buy
Price Target: $41$50
Current: $43.44
Upside: +15.10%
Insulet
Sep 29, 2025
Maintains: Buy
Price Target: $353$399
Current: $326.03
Upside: +22.38%
HeartFlow
Sep 22, 2025
Maintains: Buy
Price Target: $35$39
Current: $41.00
Upside: -4.88%
Neuronetics
Aug 6, 2025
Maintains: Buy
Price Target: $8$7
Current: $3.11
Upside: +125.08%
Maintains: Hold
Price Target: $75$81
Current: $76.89
Upside: +5.35%
Maintains: Buy
Price Target: $97$90
Current: $62.91
Upside: +43.06%
Maintains: Hold
Price Target: $115$101
Current: $103.21
Upside: -2.14%
Maintains: Buy
Price Target: $23$18
Current: $10.19
Upside: +76.64%
Maintains: Buy
Price Target: $11
Current: $5.15
Upside: +113.59%
Maintains: Buy
Price Target: $66$52
Current: $37.50
Upside: +38.67%
Maintains: Buy
Price Target: $33
Current: $12.94
Upside: +155.02%
Maintains: Buy
Price Target: $12$15
Current: $7.10
Upside: +111.27%
Reiterates: Buy
Price Target: $284
Current: $254.11
Upside: +11.76%
Maintains: Buy
Price Target: $22$25
Current: $16.15
Upside: +54.80%
Maintains: Buy
Price Target: $20$12
Current: $1.61
Upside: +647.66%
Maintains: Hold
Price Target: $86$70
Current: $83.85
Upside: -16.51%
Downgrades: Hold
Price Target: $77$48
Current: $27.04
Upside: +77.51%